# Coeptis Therapeutics, Inc. — Regulation A 1-A

Coeptis Therapeutics, Inc. of WEXFORD, PA filed a Regulation A 1-A with the SEC on 2021-11-18. Aggregate offering: $12.0M (Tier 2). Industry: Other.

## Offering

- Filed: 2021-11-18
- Form: 1-A
- Accession: 0001683168-21-005805
- Tier: Tier 2
- Total aggregate offering: $12.0M
- Issuer portion: $12.0M
- Price per security: $4.0000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Turner, Stone & Company, LLP
- Jurisdictions: 64 states/territories

## Issuer

- CIK: 0001819663
- Organized in: DE
- Incorporated: 1996
- Address: 105 BRADFORD RD, SUITE 420, WEXFORD, PA, 15090
- Phone: 724-934-6467
- Employees: 4 full-time, 1 part-time

## Financial snapshot (as filed)

- Total assets: $7.7M
- Cash & equivalents: $2.8M
- Total liabilities: $7.1M
- Stockholder equity: $573K
- Revenues: $75K
- Net income: $-10.6M

## People (1)

| Name | Role | Location |
| --- | --- | --- |
| Eric Newlan | Signer | Irvine, CA |

## More

- [CIK 1819663 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1819663&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/rega/0001683168-21-005805.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.